Cas no 3564-75-8 (5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)-)
![5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)- structure](https://ossimg.kuujia.com/scimg/4000/3564-75-8x500.png)
3564-75-8 structure
Product Name:5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)-
5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)- Chemical and Physical Properties
Names and Identifiers
-
- 5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)-
- 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethyl-1-pr opanamine
- (-)-Trimipramine
- 5H-Dibenz[b,f]azepine,5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-, (-)- (8CI)
- FI 6120
- Surmontyl
- Trimeproprimin
- TRIMIPRAMINE [VANDF]
- Prestwick1_000806
- 5H-DIBENZ(B,F)AZEPINE, 5-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-10,11-DIHYDRO-, D-
- CS-0013853
- 5-(.gamma.-Dimethylamino-.beta.-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
- TRIMIPRAMINE [USAN]
- Spectrum3_001151
- BRD-A19195498-050-09-1
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-, (+)-
- Trimipramine (USAN/INN)
- CCG-205230
- SDCCGSBI-0051123.P004
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-
- 5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-, (-)-
- GTPL7317
- SPBio_001320
- .beta.-Methylimipramine
- Trimipramina (INN-Spanish)
- Spectrum4_000759
- BPBio1_000739
- Trimipramine [USAN:INN:BAN]
- TRIMIPRAMINE, (-)-
- Trimipraminum
- Prestwick0_000806
- CHEMBL644
- KBioGR_001118
- Surmontil
- TRIMIPRAMINE [MART.]
- Trimeprimina
- 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine
- (3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}-2-methylpropyl)dimethylamine
- TRIMIPRAMINE (MART.)
- Rhotrimine
- DTXSID8023715
- 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine
- SCHEMBL35144
- IL-6001
- N06AA06
- NCGC00016013-03
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)-
- EN300-24410256
- RP-10663
- 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethyl-1-propanamine #
- Q423498
- 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine
- Sapilent
- BDBM50240410
- 7162-RP
- L000969
- UNII-QJ9MUH57H8
- Trimipramina
- 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, (-)-
- RP-7162
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-
- NCGC00162356-01
- TRIMIPRAMINE, (+)-
- NCGC00016013-02
- 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile [Italian]
- (+)-Trimipramine
- Trimipramine 1.0 mg/ml in Methanol
- Trimeprimine
- Spectrum5_001052
- Oprea1_375679
- D00394
- 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,.beta.-trimethyl-
- BRD-A19195498-050-05-9
- DB00726
- TRIMIPRAMINE [WHO-DD]
- UNII-6S082C9NDT
- UNII-9K5931C1H5
- InChI=1/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H
- DivK1c_000093
- AB00053646
- 6S082C9NDT
- 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethyl-1-propanamine
- 10,11-DIHYDRO-N,N,BETA-TRIMETHYL-5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE
- 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-propan-1-amine
- QJ9MUH57H8
- Prestwick2_000806
- trimipramine
- Trimeprimina [Italian]
- Lopac0_001156
- 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, (+)-
- 5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-, (+)-
- KBio2_007038
- 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-
- 5-20-08-00099 (Beilstein Handbook Reference)
- SBI-0051123.P003
- Spectrum2_001530
- 5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-
- Prestwick3_000806
- 3564-75-8
- BSPBio_000671
- FI-6120
- BRN 1321466
- 3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N,2-trimethylpropan-1-amine
- NCGC00016013-11
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-, (-)-
- BCP06247
- NINDS_000093
- 5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-
- IDI1_000093
- 10645 RP
- AKOS015962182
- NS00000421
- KBio2_001902
- 7162 RP
- AB00053646_11
- 739-71-9
- SPBio_002592
- IL 6001
- 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,beta.-trimethyl-, (2Z)-2-butenedioate (1:1)
- AB00053646_10
- 5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
- CHEBI:9738
- 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine
- (3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}-2-methylpropyl)dimethylamine
- EINECS 212-008-3
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (-)-
- 3564-66-7
- A847268
- 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-
- 10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine
- AC-15969
- 9K5931C1H5
- ZSCDBOWYZJWBIY-UHFFFAOYSA-N
- 10633 RP
- KBioSS_001902
- 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine
- BSPBio_002701
- Trimipraminum (INN-Latin)
- 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
- TRIMIPRAMINE [INN]
- TRIMIPRAMINE [MI]
- KBio1_000093
- KBio3_002201
- J-525116
- DTXCID003715
- HY-B1213A
- KBio2_004470
- FT-0764503
- Trimipramina [INN-Spanish]
- beta-Methylimipramine
- Trimipraminum [INN-Latin]
- Trimeproprimine
- Spectrum_001422
-
- Inchi： 1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3
- InChI Key： ZSCDBOWYZJWBIY-UHFFFAOYSA-N
- SMILES： N1(C2C=CC=CC=2CCC2C=CC=CC1=2)CC(C)CN(C)C
Computed Properties
- Exact Mass: 294.209599
- Monoisotopic Mass: 294.209599
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 22
- Rotatable Bond Count: 4
- Complexity: 317
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.8
- Topological Polar Surface Area: 6.5
Experimental Properties
- Density: 1.029
- Boiling Point: 411.8°Cat760mmHg
- Flash Point: 183.3°C
- LogP: 4.2
5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)- Related Literature
-
P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
-
Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
3564-75-8 (5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-, (-)-) Related Products
- 50-49-7(3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine)
- 2293-21-2(N-Demethyl Trimipramine)
- 50-47-5((3-{2-azatricyclo9.4.0.0,3,8pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)(methyl)amine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
Recommended suppliers
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Reagent
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier
CN Supplier
Bulk
